At 7.4% CAGR, Middle East & Africa Myopia Treatment Market is Projected to be Worth US$ 465.81 Million by 2030, says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa myopia treatment market was valued at US$ 263.30 million in 2022 and is expected to reach US$ 465.81 million by 2030, registering a CAGR of 7.4% from 2022 to 2030. Rising prevalence of myopia and rising availability of advanced technologies for treating the targeted myopia are among the critical factors attributed to drive the Middle East & Africa myopia treatment market growth.

The rising prevalence of myopia globally represents a significant public health concern, with increasing incidences observed among children and young adults, particularly. A recent study estimated that by 2050, nearly 50% of the world's population-or 5 billion people-will be myopic, up from the current average of 30%. it has been reported to be 42%, nearly doubling in just three decades. Multiple factors contribute to this trend, including lifestyle changes, increased urbanization, and extensive near-work activities, such as prolonged use of digital devices and limited outdoor exposure. While genetic predisposition plays a role, environmental factors also contribute to escalating the rates of myopia substantially. The impact of these lifestyle and environmental factors has led to an enhanced understanding of the complex interplay between genetic susceptibility and environmental influences, further underscoring the need for comprehensive strategies to address this burgeoning public health issue. As the prevalence of myopia continues to rise, there is a growing emphasis on developing proactive interventions, public health campaigns, and innovative treatment approaches to mitigate the long-term implications of high myopia and its associated ocular complications, thereby emphasizing the importance of addressing this multifaceted global health challenge.

On the contrary, lack of skilled professionals hurdles the growth of Middle East & Africa myopia treatment market.

Based on type, the Middle East & Africa myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held 62.6% market share in 2022, amassing US$ 164.71 million. It is projected to garner US$ 300.79 million by 2030 to register 7.8% CAGR during 2022-2030.

In terms of treatment, the Middle East & Africa myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held 38.7% share of Middle East & Africa myopia treatment market in 2022, amassing US$ 101.77 million. It is anticipated to garner US$ 185.92 million by 2030 to expand at 7.8% CAGR during 2022-2030. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the Middle East & Africa myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held 65.1% share of Middle East & Africa myopia treatment market in 2022, amassing US$ 171.33 million. It is projected to garner US$ 309.89 million by 2030 to expand at 7.7% CAGR from 2022 to 2030.

Based on end user, the Middle East & Africa myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held 65.6% share of Middle East & Africa myopia treatment market in 2022, amassing US$ 172.75 million. It is predicted to garner US$ 313.15 million by 2030 to expand at 7.7% CAGR between 2022 and 2030.

Based on country, the Middle East & Africa myopia treatment market is categorized into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 31.5% share of Middle East & Africa myopia treatment market in 2022. It was assessed at US$ 82.96 million in 2022 and is likely to hit US$ 156.23 million by 2030, registering a CAGR of 8.2% during 2022-2030.

Key players operating in the Middle East & Africa myopia treatment market are Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, and Nidek Co Ltd, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com